Maia Biotechnology, Inc. Announces $2.4 Million Financing To Advance Targeted Immuno-Oncology Studies
Amount Raised
$2.4 Million
Round Type
Seed
ChicagoBiotechnologyHealth CareScience And EngineeringMedicalTherapeuticsDescription
MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs (“MAIA”), announced today that it has raised an additional $2.4 million in an equity offering of its common stock. The proceeds of the financing will advance MAIA’s programs and will support the initiation of a Phase 2 clinical trial (THIO-101) evaluating the administration of THIO followed by cemiplimab in patients with advanced Non-Small Cell Lung Cancer (NSCLC).
Quick answer
MAIA Biotechnology raised $2.4 Million in a Seed round, dated March 16, 2022. MAIA Biotechnology is based in Chicago, Illinois, United States.
- How much did MAIA Biotechnology raise?
- MAIA Biotechnology raised $2.4 Million in a Seed round on March 16, 2022.
- What does MAIA Biotechnology do?
- MAIA is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend..
- Where is MAIA Biotechnology based and how big is it?
- MAIA Biotechnology is based in Chicago, Illinois, United States.
- Who are the decision-makers at MAIA Biotechnology?
- Fundz holds 2 contacts at MAIA Biotechnology, including the Senior Director, Human Resources. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Medical around the same time
Companies in the same sectors as MAIA Biotechnology that raised within 45 days of this round, from Fundz verified event records.
- Theriva Biologics raised $1.5M (Seed) on March 21, 2022.
- Scipher Medicine raised $110M (Funding Round) on February 24, 2022.
- IMPLICITY raised $23M (Funding Round) on April 27, 2022.
- Zentalis Pharmaceuticals raised $25M on April 27, 2022.
- MitoRx Therapeutics raised an undisclosed amount (Seed) on April 25, 2022.
- CytoDyn raised $1.9M (Seed) on April 22, 2022.
Who to call at MAIA Biotechnology, and when
A new round usually means MAIA Biotechnology is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day MAIA Biotechnology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MAIA Biotechnology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MAIA Biotechnology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MAIA Biotechnology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
MAIA Biotechnology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.